title: Multiple meningiomas.
abstract: A 57-year-old woman with hyperthyroid ophthalmopathy underwent somatostatin receptor scintigraphy with In-111 pentetreotide. She also reported migraine-type headaches over the previous 3 months, without any other obvious neurologic symptoms and signs. The study revealed an increased uptake of the radiopharmaceutical in both periorbital areas and the right lobe of the thyroid gland. Multiple foci of marked tracer uptake were also detected in the right half of the head. A brain MRI scan subsequently revealed multiple lesions consistent with meningiomas on the surface of the right cerebral hemisphere.
authors.affiliation: Nuclear Medicine Department, Alexandra University Hospital, Athens, Greece. jtkoutsik@yahoo.gr
authors.forename: A
authors.initials: A
authors.lastname: Leondi
authors.forename: V
authors.initials: V
authors.lastname: Valotassiou
authors.forename: J
authors.initials: J
authors.lastname: Koutsikos
authors.forename: S
authors.initials: S
authors.lastname: Tsiouris
authors.forename: E
authors.initials: E
authors.lastname: Mainta
authors.forename: C
authors.initials: C
authors.lastname: Zerva
mesh_terms: D001932:Brain Neoplasms / Q000000981:diagnostic imaging*; D005260:Female; D006111:Graves Disease / Q000000981:diagnostic imaging*; D006801:Humans; D033162:Incidental Findings; D008577:Meningeal Neoplasms / Q000000981:diagnostic imaging*; D008579:Meningioma / Q000000981:diagnostic imaging*; D008875:Middle Aged; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D013004:Somatostatin / Q000031:analogs & derivatives*
chemical_list: D019275:Radiopharmaceuticals; D013004:Somatostatin; C081788:pentetreotide